Physician profile
Mark Alezander Mansour
NPI 1073597241
$1,121.82
in general payments reported to CMS, 2019-2025
16 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $86.35 · 2021: $67.97 · 2022: $63.55 · 2023: $131 · 2024: $203 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422 · Education: $43.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.49 |
| Education | $43.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $256.79 | 2022-2025 | Benlysta |
| Janssen Biotech, INC. | $186.54 | 2019-2024 | Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $132.79 | 2019-2023 | Plenvu, Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $105.89 | 2019-2025 | Entyvio |
| Genzyme Corporation | $99.92 | 2019 | |
| Aurinia Pharma U.S., INC. | $95.49 | 2024 | Lupkynis |
| Merck Sharp & Dohme LLC | $37.94 | 2019 | |
| Organogenesis INC. | $34.01 | 2019 | |
| Organon LLC | $30.51 | 2024 | |
| Urgo Medical North America, LLC | $29.17 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Philips North America LLC | $22.74 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.10 | 2019 | |
| Abbvie INC. | $20.45 | 2019 | |
| Daiichi Sankyo INC. | $20.12 | 2019 | |
| Braintree Laboratories, INC. | $14.12 | 2024 | Suflave |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mansour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.